[
    [
        {
            "time": "",
            "original_text": "人民金融·创新药指数涨0.86% | 沃森生物、丽珠集团等新冠疫苗取得重要进展，智飞生物、人福医药重磅新药临近获批",
            "features": {
                "keywords": [
                    "创新药指数",
                    "新冠疫苗",
                    "沃森生物",
                    "丽珠集团",
                    "智飞生物",
                    "人福医药",
                    "重磅新药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "人民金融·创新药指数涨0.86% | 沃森生物、丽珠集团等新冠疫苗取得重要进展，智飞生物、人福医药重磅新药临近获批",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物今日大宗交易成交7万股，成交价169.0元折价19.06%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大宗交易",
                    "折价"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物今日大宗交易成交7万股，成交价169.0元折价19.06%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "2020医药板块分化：医疗高增中药化药承压 未名、舒泰神等医保出局后转亏 亏损",
            "features": {
                "keywords": [
                    "医药板块",
                    "医疗",
                    "中药",
                    "化药",
                    "未名",
                    "舒泰神",
                    "医保出局",
                    "亏损"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2020医药板块分化：医疗高增中药化药承压 未名、舒泰神等医保出局后转亏 亏损",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]